Acute Angle-Closure Glaucoma Caused by Venlafaxine

Zhou, Nan; Zhao, Jiaxin; Zhu, Yanyan; Zhang, Peng; Zuo, Yan

doi:10.4103/0366-6999.233952

Cited by 9 publications

(4 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SSRI agents have been reported to increase the intraocular pressure in another review, but this did not require discontinuation of the drugs and only required follow-up by the Ophthalmology team [9]. However, some case reports have indicated that SNRIs such as Duloxetine [2,10] and Venlafaxine [11,12], and SSRIs such as sertraline [13], paroxetine [14], and citalopram [15] can cause angle-closure glaucoma. The reason is reported in these studies as the serotonin receptors in the iris, cornea, and ciliary body.…”

Section: Review Of the Baseline And 3rd Month Results Of The Patients...mentioning

confidence: 99%

Evaluation of the effects of duloxetine treatment on anterior segment parameters by optical coherence tomography

et al. 2022

View full text Add to dashboard Cite

Purpose: To evaluate the effects of Duloxetine on anterior segment parameters and intraocular pressure(IOP) in open angle eyes. Methods: 38 eyes of 38 patients with bromyalgia who had open or wide open angles according to the Shaffer classi cation. Anterior segment optic coherence tomography was performed before and after (month 3) Duloxetine treatment. IOP, central corneal thickness(CCT), corneal endothelial cell density(CECD) and anterior chamber depth(ACD) were also recorded and evaluated.Results: No statistically signi cant difference was determined in IOP, CCT and CECD(p > 0.05). However, a statistically signi cant increase was determined in both the temporal and nasal anterior chamber angle, angle opening distance, nasal trabecular-iris space area and ACD values between the baseline and month 3 (p < 0.001). Conclusion:We think that the short term use of Duloxetine does not lead to clinically signi cant changes despite their statistically signi cant effects on the anterior chamber parameters.

show abstract

Section: Review Of the Baseline And 3rd Month Results Of The Patients...mentioning

confidence: 99%

Evaluation of the effects of duloxetine treatment on anterior segment parameters by optical coherence tomography

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The increase in glaucoma cases reported in relation to the taking of SNRI drugs such as venlafaxine makes us consider its production mechanism, with the aim of making both a diagnosis and an early treatment [1,[6][7][8]10]. In cases in which acute angle closure occurs, the first measure to take would be immediate drug withdrawal and peripheral iridotomy.…”

Section: Discussionmentioning

confidence: 99%

“…Antidepressants are drugs frequently prescribed in the normal clinical practice. Among them, tricyclics are used less and less due to their side effects, and have been replaced by new pharmacological families with a better safety profile, such as selective serotonin reuptake inhibitors or serotonin and noradrenaline reuptake inhibitors [ 1 ].…”

Section: Introductionmentioning

confidence: 99%

Bilateral acute angle closure after venlafaxine intake in a young patient with a narrow iridocorneal angle

Castrillo¹,

Cores²,

Reyes³

et al. 2021

rjo

View full text Add to dashboard Cite

show abstract

“…Regarding venlafaxine, literature reports 4 possible cases of AACG after recent administration of this antidepressant, with the onset of symptoms ranging between 4 h and 10 days. In all reported cases, the patients were females of different age (between 35 and 70 years old) and had blurred vision as a common symptom [59][60][61][62].…”

Section: Acgmentioning

confidence: 99%

Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature

Ciobanu

Dionisie

Neagu

et al. 2021

JCM

View full text Add to dashboard Cite

Through the years, the available psychopharmacological treatments have expanded with numerous new drugs. Besides weight gain, gastro-intestinal problems or Parkinson-like symptoms, ocular adverse effects of psychiatric drugs have been reported. These adverse effects are not common, but can be dangerous for the patient. This review summarises the current knowledge on the risk of raised intraocular pressure and glaucoma entailed by psychopharmacological treatment. Also, it provides updated data for clinicians involved in the treatment of patients with glaucoma or glaucoma risk factors. For this purpose, we performed an extensive literature search in the PubMed database using specific terms. Selective serotonin and noradrenaline reuptake inhibitors are the best evidenced as having no association with glaucoma. Antipsychotics, and especially first generation, seem to have no correlation with an increased intraocular pressure and therefore possibly with a risk of glaucoma, although a special attention should be paid when using ziprasidone. Tricyclic antidepressants, benzodiazepines and topiramate should be avoided in patients diagnosed with glaucoma or at risk. Clinicians should be aware of the possible psychotropic drug induced glaucoma and monitor at risk patients closely in order to prevent this condition. Irrespective of the psychopharmacological regimen taken into consideration, the glaucoma patient should be under the strict supervision of the ophthalmologist.

show abstract

Acute Angle-Closure Glaucoma Caused by Venlafaxine

Cited by 9 publications

References 5 publications

Evaluation of the effects of duloxetine treatment on anterior segment parameters by optical coherence tomography

Evaluation of the effects of duloxetine treatment on anterior segment parameters by optical coherence tomography

Bilateral acute angle closure after venlafaxine intake in a young patient with a narrow iridocorneal angle

Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature

Contact Info

Product

Resources

About